10 Most Undervalued Stocks to Buy and Hold for 3 Years

7. Lantheus Holdings Inc. (NASDAQ:LNTH)

Forward P/E Ratio as of July 22: 10.55

3-Year Revenue CAGR: 41.57%

Number of Hedge Fund Holders: 43

Lantheus Holdings Inc. (NASDAQ:LNTH) is one of the most undervalued stocks to buy and hold for 3 years. Earlier on June 23, B. Riley analyst Yuan Zhi reduced the firm’s price target on Lantheus from $122 to $109, while maintaining a Buy rating on the shares. The adjustment was made following the company’s Q1 2025 financial update.

In Q1 2025, the company announced consolidated net revenue of $372.8 million, which was a 0.8% increase year-over-year. PYLARIFY sales were $257.7 million and remained flat compared to the prior year. Precision Diagnostic revenue was $104.4 million, also flat year-over-year. DEFINITY sales increased by 3.5% to $79.2 million, while TechneLite revenue decreased by 9.2% to $19.7 million due to a brief supply issue.

Lantheus experienced a decrease in profitability in Q1. Gross profit margin fell by 180 basis points to 67%. Operating expenses increased to 28.3% of net revenue, 1.47% higher than the prior year. As a result, operating profit decreased by 7.1% to $144.3 million. As of the end of Q1 2025, cash and cash equivalents stood at $938.5 million.

Lantheus Holdings Inc. (NASDAQ:LNTH) develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.